| PHUSE US |
2026 |
Optimising Trial Design Dataset Creation To Minimise P21 Compliance Issues |
|
source presentation source |
6 |
| PHUSE US |
2025 |
Evolution of Genomic Data Mapping from PF to GF in SDTM v3.4: Concepts, Challenges and Controlled Terminology with Genetic Variation Examples |
|
source presentation source |
7 |
| PHUSE US |
2025 |
How Unique is it for the Subject Identifier in a Study To Have Multiple Screenings and Enrolments? |
Anahita Vyas |
source presentation source |
8 |
| PharmaSUG |
2018 |
Complexity in collection of PGx data and challenges in mapping to SDTM |
|
source |
9 |